Best Hospitals for Facial Implants in Hyderabad, India

Facial implants surgery at GAF Healthcare's accredited partner hospitals costs approximately USD 2,500 to USD 7,500 in India and USD 5,000 to USD 14,000 in the UAE (Dubai/Abu Dhabi). India is typically 40–60% more affordable than the UAE for equivalent surgical quality, largely due to lower hospital infrastructure and labour costs — not reduced standards of care. Both destinations offer JCI-accredited or DHA-licensed hospitals with board-certified plastic and craniofacial surgeons using internationally recognised implant systems (Implantech, Stryker Leibinger, Materialise). The lower end of each range applies to single-site augmentation (e.g., isolated chin implant) using standard off-the-shelf silicone implants in a mid-tier accredited hospital. The upper end reflects multi-site augmentation (e.g., simultaneous chin, malar, and mandibular angle implants), patient-specific CAD/CAM implants, combination procedures (rhinoplasty, facelift), or premium private hospitals with concierge-level services. Package inclusions at both destinations typically cover surgeon's fee, anaesthesia, operating theatre, the implant itself, 1–2 nights hospital accommodation, and routine post-operative medications. International flights, personal insurance, and elective upgrades are additional. GAF Healthcare provides a detailed, itemised cost estimate at no charge following your virtual consultation.

A minimum in-country stay of 14 days (2 weeks) is required before you will be medically cleared to board an international flight, and a stay of 21 days (3 weeks) is the recommended standard for patients undergoing multi-site or combined procedures. This timeline is determined by several physiological milestones that must be confirmed by your surgeon before fit-to-fly status is granted. During the first 72 hours, swelling peaks and the implant is at its greatest risk of displacement from external pressure or movement. By Day 7–10, intraoral wounds are sufficiently epithelialised and the risk of wound dehiscence on chewing or speaking is substantially reduced. At Day 14, approximately 60–70% of post-operative oedema has resolved, the implant has achieved initial fibrous stabilisation within its pocket, and the risk of haematoma is negligible — making short-to-medium-haul flights (under 5–6 hours) appropriate. For long-haul flights (8+ hours), the 21-day mark is preferred because prolonged cabin pressure changes and immobility can exacerbate residual swelling and increase deep vein thrombosis (DVT) risk in any post-surgical patient. Your in-country stay will include at minimum two post-operative review appointments with your surgeon (typically at Day 5–7 and Day 12–14) before fit-to-fly clearance is formally documented in your discharge summary. GAF Healthcare's accommodation partners provide comfortable, medically proximate short-stay options for the full 2–3 week recovery period at pre-negotiated rates.

Facial implants surgery performed by experienced craniofacial or plastic surgeons at accredited centres carries an overall patient satisfaction and procedural success rate of 92–95%, based on peer-reviewed outcomes literature and registry data from high-volume centres in the USA, Europe, South Korea, and India. 'Success' in this context is defined as implant remaining in correct position, absence of major complications (infection, persistent nerve injury, or implant removal) at 12-month follow-up, and patient-reported satisfaction with aesthetic outcome. The revision rate — surgery to correct malposition, asymmetry, or size — is reported at 4–8% across modalities, with patient-specific implants (PSI) consistently demonstrating revision rates at the lower end of this range (2–4%) compared to off-the-shelf devices. Infection rates requiring implant removal are reported at less than 1% in non-smoking, medically optimised patients at JCI-accredited hospitals. Long-term implant survival — meaning the implant remains in place and functional without explantation — exceeds 95% at 10-year follow-up for silicone and Medpor devices in appropriately selected patients. Factors that significantly improve individual success rates include 3D virtual surgical planning, intraoperative CT guidance or navigation in complex cases, screw fixation for high-mobility sites, and meticulous patient selection excluding those with active infection, uncontrolled diabetes, or active smoking. GAF Healthcare's partner hospitals report success rates consistent with or exceeding international benchmarks, supported by independent JCI accreditation audits and internal quality improvement programmes.